Podcast As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon May 27, 2026
Capitol HillNCI NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing May 22, 2026Vol.52 No.20By Jacquelyn Cobb
Capitol Hill USPSTF leaders John Wong and Esa Davis fired by Kennedy, leaving the panel rudderless May 22, 2026Vol.52 No.20By Claire Marie Porter
NCI At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylinesThere’s “clear evidence that funding is moving and the system is working.” April 24, 2026Vol.52 No.16By Sara Willa Ernst
In Brief Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years April 17, 2026Vol.52 No.15
Podcast NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown April 15, 2026
Conversation with The Cancer Letter Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdyNCI expects record-breaking spending on extramural research April 10, 2026Vol.52 No.14By Claire Marie Porter and Paul Goldberg
PodcastThe Directors The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes March 27, 2026Vol.52 No.12By Sara Willa Ernst and Paul Goldberg
Podcast At a jam-packed NCAB meeting, cancer vaccines and site visits take center stage March 25, 2026
NCI Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccinesNCI Director Letai: “How aggressive can we be?” March 20, 2026Vol.52 No.11By Claire Marie Porter
